| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |